Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.5M Buy
474,713
+64,503
+16% +$2.83M ﹤0.01% 1897
2026
Q1
$19.3M Buy
410,210
+65,669
+19% +$2.57M ﹤0.01% 1766
2025
Q4
$12M Buy
344,541
+44,673
+15% +$1.57M ﹤0.01% 2045
2025
Q3
$10.3M Buy
299,868
+63,119
+27% +$2.11M ﹤0.01% 2099
2025
Q2
$7.09M Sell
236,749
-400
-0.2% -$11.7K ﹤0.01% 2173
2025
Q1
$8.01M Buy
237,149
+48,090
+25% +$1.57M ﹤0.01% 2054
2024
Q4
$5.59M Buy
189,059
+81,259
+75% +$2.44M ﹤0.01% 2290
2024
Q3
$3.38M Sell
107,800
-17,795
-14% -$602K ﹤0.01% 2548
2024
Q2
$4.53M Buy
125,595
+21,716
+21% +$814K ﹤0.01% 2401
2024
Q1
$3.91M Buy
103,879
+35,641
+52% +$1.28M ﹤0.01% 2375
2023
Q4
$2.42M Buy
68,238
+8,735
+15% +$320K ﹤0.01% 2554
2023
Q3
$2.3M Buy
59,503
+26,764
+82% +$993K ﹤0.01% 2554
2023
Q2
$1.16M Buy
32,739
+11,467
+54% +$424K ﹤0.01% 2712
2023
Q1
$807K Buy
21,272
+8,921
+72% +$333K ﹤0.01% 2813
2022
Q4
$431K Buy
+12,351
New +$411K ﹤0.01% 3037
2020
Q4
Sell
-22,693
Closed -$396K 3398
2020
Q3
$396K Buy
+22,693
New +$491K ﹤0.01% 2948

Other funds holding BP

Charles Schwab's BP Position: Q2 2026 in Review

Charles Schwab increased its BP (BP) stake by 16% in Q2 2026, buying an estimated $2.83M and bringing the position to 474,713 shares worth $17.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1897.

Charles Schwab first reported a position in BP in Q3 2020 and has held it in 16 quarters since. The position peaked at $19.3M in Q1 2026. 1,162 funds tracked by Wall St. Rank hold BP as of Q2 2026.

  • Charles Schwab held 474,713 shares of BP worth $17.5M as of Q2 2026.
  • Charles Schwab bought 64,503 BP shares in Q2 2026, an estimated $2.83M.
  • BP made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #1897 holding.
  • Charles Schwab first reported a position in BP in Q3 2020 and has held it in 16 quarters since.
  • Charles Schwab's BP position peaked at $19.3M in Q1 2026.
  • 1,162 funds tracked by Wall St. Rank held BP as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.